NMC Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2013 | 85.07M | -108.08M | 20.28M |
|---|---|---|---|
| 2014 | 85.68M | -27.05M | -1.51M |
| 2015 | 84.08M | -424.51M | 288.13M |
| 2016 | 176.37M | -370.36M | 543.36M |
| 2017 | 277.51M | -721.23M | 216.78M |
| 2018 | 387.82M | -678.57M | 392.36M |
| 2019 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 |
NMMCF Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 0 | 0 | 324.02M | 206.46M | 433.40M | 84.02M | 136.31M | 79.20M | 81.93M |
Operating activities | ||||||||||
Net income | 0 | 0 | 0 | 0 | 256.85M | 210.42M | 151.57M | 85.35M | 77.53M | 69.14M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 100.36M | 70.88M | 55.99M | 35.32M | 14.05M | 9.66M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 9.70M | 9.18M | 2.64M | 1.17M | 88K | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 9.70M | 9.18M | 2.64M | 1.17M | 88K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | -47.29M | -83.41M | -71.56M | -54.12M | -28.08K | 0 |
Inventories | 0 | 0 | 0 | 0 | -50.13M | -28.21M | -8.63M | -19.13M | -16.08M | -21.66M |
Accounts payable | 0 | 0 | 0 | 0 | -18.87M | 12.13M | 14.21M | 1.24M | 0 | 0 |
Cash generated by operating activities | 0 | 0 | 0 | 0 | 387.82M | 277.51M | 176.37M | 84.08M | 85.68M | 85.07M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -43.82M | -40.75M | -4.48M | -3.33M | 0 | -12.25M |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | -164.98M | -64.86M | -60.04M | -79.84M | -111.26M | -78.61M |
Acquisitions Net | 0 | 0 | 0 | 0 | -482.97M | -650.34M | -246.82M | -375.50M | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | -678.57M | -721.23M | -370.36M | -424.51M | -27.05M | -108.08M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 2.56B | 0 | 314.97M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | -35.73M | -27.77M | -16.35M | -15.86M | -13.84M | -11.59M |
Repurchases of common stock | 0 | 0 | 0 | 0 | -3.6M | 0 | 944.91M | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -2.03B | 330.69M | -698.21M | 335.12M | -621.29M | -753.39M |
Cash used in financing activities | 0 | 0 | 0 | 0 | 392.36M | 216.78M | 543.36M | 288.13M | -1.51M | 20.28M |
Net Change In Cash | 0 | 0 | 0 | 0 | 101.61M | -226.94M | 349.37M | -52.29M | 57.11M | -2.72M |
Cash at end of period | 0 | 0 | 0 | 324.02M | 308.07M | 206.46M | 433.40M | 84.02M | 136.31M | 79.20M |